ID   SUIT-58
AC   CVCL_1Y17
SY   SUIzo Tumor-58
DR   Wikidata; Q54970819
RX   PubMed=26141632;
RX   PubMed=32780825;
CC   Population: Japanese.
CC   Doubling time: 32 hours (PubMed=26141632).
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
ST   Source(s): PubMed=26141632
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 9,12
ST   D16S539: 9,11
ST   D21S11: 31
ST   D5S818: 10,12
ST   D7S820: 11,12
ST   TH01: 6,9
ST   TPOX: 8
ST   vWA: 18
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   77Y
CA   Cancer cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
CH   CVCL_1Y18 ! S58-SF
//
RX   PubMed=32780825; DOI=10.1093/jmicro/dfaa046;
RA   Takahashi, Nobuyasu
RA   Aoyama, Fumiyo
RA   Sawaguchi, Akira
RT   "Three-dimensional culture of a pancreatic cancer cell line, SUIT-58,
RT   with air exposure can reflect the intrinsic features of the original
RT   tumor through electron microscopy.";
RL   Microscopy (Oxf.) 70:192-200(2021).
//
RX   PubMed=26141632; DOI=10.1007/s13577-015-0122-6;
RA   Takahashi, Nobuyasu
RA   Aoyama, Fumiyo
RA   Ohuchida, Jiro
RA   Sameshima, Naoki
RA   Asada, Yujiro
RA   Sawaguchi, Akira
RT   "Establishment and characterization of SUIT-58 pancreas cancer cell
RT   line and its subline S58-SF adapted to serum-free condition derived
RT   from metastatic liver tumor.";
RL   Hum. Cell 28:190-198(2015).
//